The MIROCALS consortium is delighted to announce that the first participant has been recruited to the MIROCALS trial, at Hospices Civils de Lyon, France.
The MIROCALS consortium is delighted to announce that the first participant has been recruited to the MIROCALS trial, at Hospices Civils de Lyon, France.
The MIROCALS (Modifying Immune Response and Outcomes in ALS) Clinical Trial is still on-going, with recruitment continuing until the end of September 2019.
Read moreClinical trials are expensive to run and with several more neurology clinics taking part, ...
Read moreAs with everything else affected by Brexit, there are probably more questions than answers!
Read more
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 633413.